Skip to main content

UBS Group AG

Position in BLRX — BioLineRx Ltd.

CIK 1610520 ZURICH, V8

Position in BLRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$315
-$901 QoQ
Shares Held
101
-80.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 14 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BLRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. BLRX ranks #527 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BLRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $315 101
2026-03-31 $1,216 529
2025-12-31 $5,404 1,951
2025-09-30 $24,142 6,387
2025-03-31 $210 71
2024-12-31 $1,931 9,196
2024-09-30 $531 984
2024-06-30 $843 1,480
2024-03-31 $14,077 12,569
2023-12-31 $471 300
2023-09-30 $16,891 9,281
2023-06-30 $16,859 10,537
2022-12-31 $2,257 3,826
2022-09-30 $11,897 12,793
2021-06-30 $17,691 6,296
2021-03-31 $20,269 7,265
2020-12-31 $15,256 6,054
2020-09-30 $6,845 4,174